ch env tech&bio (01237.HK) received a shareholding of 9.73 million shares of common stock from Wu Baozhen off the exchange, worth approximately 3.1623 million Hong Kong dollars.
On November 26, according to documents disclosed by the Hong Kong Stock Exchange on November 26, Wu Baozhen increased his shareholding in ch env tech&bio (01237.HK) by an average price of HK$0.325 per share off-exchange, acquiring 9.73 million ordinary shares, valued at approximately HK$3.1623 million. After the increase, Wu Baozhen's latest number of shareholdings is 9.73 million shares, with a stake rising from 0.00% to 10.56%. Image Source: HKEx Shareholding Disclosure. What is equity disclosure? As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of shares) must disclose their share holdings in listed companies.
Ch Env Tech&Bio (01237.HK) received an off-market shareholding of 9.7571 million ordinary shares by Zheyan Wu, worth approximately 3.1711 million Hong Kong dollars.
On November 26, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on November 26, Zheyan Wu increased his shareholding of $ch env tech&bio (01237.HK) by 9.7571 million ordinary shares at an average price of 0.325 HKD per share in the over-the-counter market on November 6, worth approximately 3.1711 million HKD. After the increase, Zheyan Wu's latest shareholding is 11.4595 million shares, with the proportion of good shares rising from 1.85% to 12.44%. Source of the image: Stock disclosure by the Stock Exchange. What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals holding 5% or more of shares)...
Change of auditors at ch env tech&bio (01237.HK)
Ch env tech&bio (01237.HK) announced that due to the insufficient resources of the central principal global accounting firm to handle the audit of the group's consolidated financial statements as of December 31, 2024, the central principal global has resigned as the company's auditor, effective as of yesterday (11th). In addition, the board of directors has decided to appoint Olaf International Accounting Firm as the company's new auditor to fill the temporary vacancy caused by the resignation of the central principal global, with a term until the end of the company's next shareholder annual meeting. (js/w)~
ch env tech&bio appointed O'Boyle International Certified Public Accountants as the new auditor.
Ch env tech&bio (01237) announced that due to the insufficient resources of the company's auditor, Ch Zhuhuan Global Certified Public Accountants, to handle the group's consolidated financial statements audit as of December 31, 2024, Ch Zhuhuan Global has resigned as the company's auditor effective November 11, 2024. Upon the recommendation of the Audit Committee, it was decided to appoint OBO International Certified Public Accountants as the company's new auditor to fill the temporary vacancy caused by the resignation of Ch Zhuhuan Global, with a term ending at the conclusion of the company's next annual general meeting of shareholders.
ch env tech&bio (01237) appointed BDO International as the new auditor.
Ch env tech&bio (01237) announced that due to inadequate resources at Chong Hoi Global Limited's accounting firm to handle the collection...
CH ENV TECH&BIO: Interim Report 2024
ch env tech&bio (01237.HK) saw a slight increase of 4% in mid-year earnings to 0.1865 billion yuan.
Ch env tech&bio (01237.HK) announced on August 30 that the group's income for the six months ended June 30, 2024, slightly increased by 4% to 18.65 million yuan compared to the same period last year. During the period, the group's gross margin was 7.2% (first half of 2023: 12.1%). The group's gross profit was 13.4 million yuan (first half of 2023: 21.7 million yuan).
CH ENV TECH&BIO: 2024 INTERIM RESULTS ANNOUNCEMENT
In the profit warning, Ch Env Tech&Bio (01237.HK) is estimated to have a loss of 2 million RMB in the first half of the year.
Ch env tech&bio (01237.HK) issued a profit warning, expecting a loss of 2 million yuan for the six months ending in June, compared to a profit of 2.7 million RMB in the same period last year. This is mainly due to the decline in gross margin of sales.
ch env tech&bio (01237) issued a profit warning, expecting a net loss of approximately 2 million yuan in the medium term.
ch env tech&bio (01237) announced that compared to the net surplus earned for the six months ended June 30, 2023...
Ch Env Tech&Bio (01237.HK): Wu Liping was appointed as an independent non-executive director.
On July 29th, Ge Long Hui reported that Ch Env Tech&Bio (01237.HK) announced that, effective July 29th, 2024: (1) Jin Zhongwei resigned as an independent non-executive director, chairman of the company's remuneration committee and nomination committee, as well as a member of the company's audit committee and risk management committee; (2) Su Wenqiang resigned as an independent non-executive director, member of the remuneration committee, nomination committee, audit committee and risk management committee; (3) Wu Liping was appointed as an independent non-executive director, chairman of the remuneration committee, and a member of the nomination committee, audit committee and risk management committee; (4) Zheng Bingqian was appointed as an independent
Express News | *ST Ningke: The company and its subsidiaries have not received court documents to accept pre-restructuring and restructuring
CH ENV TECH&BIO: 2023 ANNUAL REPORT
Zhongke Biotech (01237) grants 3.9 million bonus shares
Zhongke Biotech (01237) issued an announcement. On April 15, 2024, in accordance with the terms of the share award plan...
Zhongke Biotech (01237) announced annual results. Losses attributable to shareholders of 2.364 million yuan narrowed by 63.95% year-on-year
According to Zhitong Finance App, Zhongke Biotech (01237) announced its annual results for the year ended December 31, 2023. The group achieved revenue of 298 million yuan (RMB, same below), a year-on-year decrease of 36.02%; shareholders' losses of 2.364 million yuan, a year-on-year narrowing of 63.95%; the basic loss per share was 0.03 yuan; the announcement stated that in the reporting year, wood products revenue was still the Group's largest source of revenue. Revenue in this category fell 36.0% to $295 million (2022: $461 million), accounting for 99.2% of total sales for the reporting year (2022:99.1 million)
CH ENV TECH&BIO: ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Zhongke Biotech (01237) issued a profit warning. The annual net loss is expected to decrease by about 65% year on year
Zhongke Biotech (01237) announced that the Group expects to achieve net results for the year ending December 31, 2023...
CH ENV TECH&BIO: PROFIT WARNING
Zhongke Biotech (01237.HK) held a board meeting on March 28 to approve annual results
Gelonghui March 15 | Zhongke Biotech (01237.HK) announced that the company will approve the annual results announcements of the company and its subsidiaries for the year ended December 31, 2023 for publication at the board meeting to be held on March 28, 2024, and is expected to implement the dividend payment proposal (if any) and handle other matters.
Express News | Ningxia Zhongke Biotechnology was forcibly executed for 0.11 billion.